Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Tenowel E Tenofovir Lamivudine & Efavirenz Tablets:
Tenowel E is a powerful combination therapy for the treatment of HIV infection. It combines Tenofovir, Lamivudine, and Efavirenz to effectively block HIV replication, reduce viral load, and support immune function.
Uses of Tenowel E Tenofovir Lamivudine & Efavirenz Tablets:
Tenowel E is used in the treatment of HIV-1 infection, as part of a combination antiretroviral therapy (ART). It helps to control the viral load and improve immune response in individuals living with HIV.
Benefits of Tenowel E Tenofovir Lamivudine & Efavirenz Tablets:
Combines three active ingredients for enhanced viral suppression
Reduces HIV viral load and increases CD4+ T cell count
Improves immune function and helps delay the progression to AIDS
Convenient once-daily oral administration
Mechanism of Action of Tenowel E Tenofovir Lamivudine & Efavirenz Tablets:
Tenofovir and Lamivudine are both nucleoside reverse transcriptase inhibitors (NRTIs) that block the reverse transcriptase enzyme, inhibiting the conversion of viral RNA into DNA. Efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI), binds to reverse transcriptase, preventing the enzyme from functioning properly. This combination of medications effectively inhibits HIV replication, leading to reduced viral load and improved immune system function.